v3.26.1
Insider Trading Arrangements
3 Months Ended
Jun. 30, 2026
shares
Trading Arrangements, by Individual  
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
Daniel O’Connell [Member]  
Trading Arrangements, by Individual  
Material Terms of Trading Arrangement
On June 29, 2026, Daniel O’Connell, our Chief Executive Officer and a member of our board of directors, entered into a Rule 10b5-1 trading plan that provides that Mr. O’Connell, acting through a broker, may sell the number of shares of common stock sufficient to cover the taxes, commissions and any fees associated with the vesting of up to 299,800 RSU awards granted to Mr. O’Connell as equity compensation, which sales may occur from January 21, 2027 to December 31, 2029. On June 30, 2026, Mr.O’Connell also entered into a separate Rule 10b5-1 trading plan that provides that Mr. O’Connell, acting through a broker, may sell (1) 294,858 shares of our common stock and (2) 418,903 shares of our common stock received upon the exercise of option awards granted to Mr.O’Connell as equity incentive compensation, which sales may occur from September 29, 2026 to June 30, 2027.
Matthew Zuga [Member]  
Trading Arrangements, by Individual  
Material Terms of Trading Arrangement
On June 29, 2026, Matthew Zuga, our Chief Financial Officer and Chief Business Officer, entered into a Rule 10b5-1 trading plan that provides that Mr. Zuga, acting through a broker, may sell the number of shares of common stock sufficient to cover the taxes, commissions and any fees associated with the vesting of up to 99,133 RSU awards granted to Mr. Zuga as equity incentive compensation, which sales may occur from January 19, 2027 to December 31, 2029. On June 29, 2026, Mr. Zuga also entered into a separate Rule 10b5-1 plan that provides that Mr. Zuga, acting through a broker, may sell 616,591 shares of our common stock received upon the exercise of option awards granted to Mr. Zuga as equity incentive compensation, which sales may occur from September 28, 2026 to September 28, 2027.
Amy Schacterle [Member]  
Trading Arrangements, by Individual  
Material Terms of Trading Arrangement
On June 30, 2026, Amy Schacterle, Ph.D., our Chief Regulatory Officer and Head of Quality, entered into a Rule 10b5-1 trading plan that provides that Dr. Schacterle, acting through a broker, may sell 147,500 shares of our common stock received upon the exercise of option awards and 31,133 shares of our common stock received upon the settlement of RSU awards granted to Dr. Schacterle as equity incentive compensation, which sales may occur from October 1, 2026 to December 31, 2027. On June 30, 2026, Dr. Schacterle also entered into a separate Rule 10b5-1 plan that provides that Dr. Schacterle, acting through a broker, may sell the number of shares of common stock sufficient to cover the taxes, commissions and any fees associated with the vesting of up to 84,600 RSU awards granted to Dr. Schacterle as equity incentive compensation, which sales may occur from January 19, 2027 to December 31, 2029.
Daniel O’Connell, June 29, 2026 Plan [Member] | Daniel O’Connell [Member]  
Trading Arrangements, by Individual  
Name Daniel O’Connell
Title Chief Executive Officer and a member of our board of directors
Rule 10b5-1 Arrangement Adopted true
Adoption Date June 29, 2026
Expiration Date December 31, 2029
Arrangement Duration 1075 days
Aggregate Available 299,800
Daniel O’Connell, June 30, 2026 Plan [Member] | Daniel O’Connell [Member]  
Trading Arrangements, by Individual  
Name Daniel O’Connell
Title Chief Executive Officer and a member of our board of directors
Rule 10b5-1 Arrangement Adopted true
Adoption Date June 30, 2026
Expiration Date June 30, 2027
Arrangement Duration 274 days
Daniel O’Connell, June 30, 2026 Plan, Shares Of Common Stock [Member] | Daniel O’Connell [Member]  
Trading Arrangements, by Individual  
Aggregate Available 294,858
Daniel O’Connell, June 30, 2026 Plan, Shares Of Common Stock Received Upon Exercise Of Options Awards [Member] | Daniel O’Connell [Member]  
Trading Arrangements, by Individual  
Aggregate Available 418,903
Matthew Zuga Plan 1 [Member] | Matthew Zuga [Member]  
Trading Arrangements, by Individual  
Name Matthew Zuga
Title Chief Financial Officer and Chief Business Officer
Rule 10b5-1 Arrangement Adopted true
Adoption Date June 29, 2026
Expiration Date December 31, 2029
Arrangement Duration 1077 days
Aggregate Available 99,133
Matthew Zuga Plan 2 [Member] | Matthew Zuga [Member]  
Trading Arrangements, by Individual  
Name Matthew Zuga
Title Chief Financial Officer and Chief Business Officer
Rule 10b5-1 Arrangement Adopted true
Adoption Date June 29, 2026
Expiration Date September 28, 2027
Arrangement Duration 365 days
Aggregate Available 616,591
Amy Schacterle Plan 1 [Member] | Amy Schacterle [Member]  
Trading Arrangements, by Individual  
Name Amy Schacterle
Title Chief Regulatory Officer and Head of Quality
Rule 10b5-1 Arrangement Adopted true
Adoption Date June 30, 2026
Expiration Date December 31, 2027
Arrangement Duration 456 days
Amy Schacterle Plan 2 [Member] | Amy Schacterle [Member]  
Trading Arrangements, by Individual  
Name Amy Schacterle
Title Chief Regulatory Officer and Head of Quality
Rule 10b5-1 Arrangement Adopted true
Adoption Date June 30, 2026
Expiration Date December 31, 2029
Arrangement Duration 1077 days
Aggregate Available 84,600
Amy Schacterle Plan 1, Shares Of Common Stock Received Upon Exercise Of Option Awards [Member] | Amy Schacterle [Member]  
Trading Arrangements, by Individual  
Aggregate Available 147,500
Amy Schacterle Plan 1, Shares Of Common Stock Received Upon Settlement Of RSU Awards [Member] | Amy Schacterle [Member]  
Trading Arrangements, by Individual  
Aggregate Available 31,133